Live Earnings Conference Call: GeoVax Labs will host a live Q1 2025 earnings call on May 1, 2025 at 4:30PM ET. Follow this link to get details and listen to GeoVax Labs' Q1 2025 earnings call when it goes live. Get details. GeoVax Labs (GOVX) Competitors $0.98 -0.03 (-3.14%) As of 10:15 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GOVX vs. CNTB, MRSN, SKYE, SPRO, TNYA, OKYO, RNTX, ANEB, AADI, and APLTShould you be buying GeoVax Labs stock or one of its competitors? The main competitors of GeoVax Labs include Connect Biopharma (CNTB), Mersana Therapeutics (MRSN), Skye Bioscience (SKYE), Spero Therapeutics (SPRO), Tenaya Therapeutics (TNYA), OKYO Pharma (OKYO), Rein Therapeutics (RNTX), Anebulo Pharmaceuticals (ANEB), Aadi Bioscience (AADI), and Applied Therapeutics (APLT). These companies are all part of the "pharmaceutical products" industry. GeoVax Labs vs. Connect Biopharma Mersana Therapeutics Skye Bioscience Spero Therapeutics Tenaya Therapeutics OKYO Pharma Rein Therapeutics Anebulo Pharmaceuticals Aadi Bioscience Applied Therapeutics Connect Biopharma (NASDAQ:CNTB) and GeoVax Labs (NASDAQ:GOVX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, community ranking, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings. Does the media refer more to CNTB or GOVX? In the previous week, GeoVax Labs had 2 more articles in the media than Connect Biopharma. MarketBeat recorded 4 mentions for GeoVax Labs and 2 mentions for Connect Biopharma. GeoVax Labs' average media sentiment score of 0.78 beat Connect Biopharma's score of 0.30 indicating that GeoVax Labs is being referred to more favorably in the news media. Company Overall Sentiment Connect Biopharma Neutral GeoVax Labs Positive Do insiders and institutionals hold more shares of CNTB or GOVX? 58.7% of Connect Biopharma shares are held by institutional investors. Comparatively, 6.1% of GeoVax Labs shares are held by institutional investors. 22.6% of Connect Biopharma shares are held by company insiders. Comparatively, 5.7% of GeoVax Labs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Do analysts rate CNTB or GOVX? Connect Biopharma currently has a consensus price target of $8.00, indicating a potential upside of 866.18%. GeoVax Labs has a consensus price target of $12.90, indicating a potential upside of 1,218.61%. Given GeoVax Labs' stronger consensus rating and higher probable upside, analysts clearly believe GeoVax Labs is more favorable than Connect Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Connect Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00GeoVax Labs 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.29 Is CNTB or GOVX more profitable? Connect Biopharma's return on equity of 0.00% beat GeoVax Labs' return on equity.Company Net Margins Return on Equity Return on Assets Connect BiopharmaN/A N/A N/A GeoVax Labs N/A -809.87%-349.34% Which has more volatility & risk, CNTB or GOVX? Connect Biopharma has a beta of -0.22, indicating that its stock price is 122% less volatile than the S&P 500. Comparatively, GeoVax Labs has a beta of 3.7, indicating that its stock price is 270% more volatile than the S&P 500. Which has better valuation and earnings, CNTB or GOVX? GeoVax Labs has lower revenue, but higher earnings than Connect Biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioConnect Biopharma$24.12M1.90-$59.50MN/AN/AGeoVax Labs$3.95M3.42-$25.97M-$5.67-0.17 Does the MarketBeat Community prefer CNTB or GOVX? GeoVax Labs received 10 more outperform votes than Connect Biopharma when rated by MarketBeat users. Likewise, 96.67% of users gave GeoVax Labs an outperform vote while only 73.08% of users gave Connect Biopharma an outperform vote. CompanyUnderperformOutperformConnect BiopharmaOutperform Votes1973.08% Underperform Votes726.92% GeoVax LabsOutperform Votes2996.67% Underperform Votes13.33% SummaryGeoVax Labs beats Connect Biopharma on 11 of the 16 factors compared between the two stocks. Get GeoVax Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for GOVX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GOVX vs. The Competition Export to ExcelMetricGeoVax LabsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.54M$6.75B$5.51B$7.93BDividend YieldN/A3.05%5.11%4.22%P/E Ratio-0.177.3222.5518.49Price / Sales3.42239.19394.97102.66Price / CashN/A65.8538.1834.62Price / Book0.306.436.694.25Net Income-$25.97M$143.21M$3.22B$248.31M7 Day Performance-2.17%1.24%1.11%1.12%1 Month Performance-9.42%6.09%3.59%3.68%1 Year Performance-33.90%-3.34%15.65%5.19% GeoVax Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GOVXGeoVax Labs2.7823 of 5 stars$0.98-3.1%$12.90+1,218.6%-27.9%$13.54M$3.95M-0.1710CNTBConnect Biopharma2.5974 of 5 stars$0.75+0.8%$8.00+973.8%-40.9%$41.24M$24.12M0.00110MRSNMersana Therapeutics3.8812 of 5 stars$0.33-7.8%$4.00+1,123.6%-86.3%$40.74M$40.50M-0.54150Upcoming EarningsNews CoverageGap DownSKYESkye Bioscience1.3431 of 5 stars$1.53-44.1%$16.60+988.5%-83.1%$40.58MN/A-1.9911SPROSpero Therapeutics4.3274 of 5 stars$0.73-3.9%$5.00+589.7%-53.7%$40.53M$27.40M10.36150Short Interest ↑TNYATenaya Therapeutics3.7799 of 5 stars$0.46+1.8%$6.25+1,264.0%-89.5%$40.13MN/A-0.32110Short Interest ↓OKYOOKYO Pharma2.7726 of 5 stars$1.17-4.1%$7.00+498.3%+5.7%$39.59MN/A0.007Short Interest ↓News CoverageGap UpRNTXRein TherapeuticsN/A$1.78+4.7%N/AN/A$39.15MN/A-0.579News CoverageANEBAnebulo Pharmaceuticals2.018 of 5 stars$0.95-5.9%$8.00+742.1%-58.3%$39.03MN/A-3.394Short Interest ↑News CoverageGap UpAADIAadi BioscienceN/A$1.57+1.9%$1.67+6.2%-22.9%$38.77M$25.07M-0.6940Upcoming EarningsAPLTApplied Therapeutics4.0849 of 5 stars$0.33-0.1%$6.10+1,734.0%-90.7%$38.70M$455,000.00-0.2130Upcoming EarningsNews CoveragePositive News Related Companies and Tools Related Companies CNTB Competitors MRSN Competitors SKYE Competitors SPRO Competitors TNYA Competitors OKYO Competitors RNTX Competitors ANEB Competitors AADI Competitors APLT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GOVX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeoVax Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeoVax Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GOVX Stock Free GOVX Stock Alerts